Pharmocann Global Bilan de santé
Santé financière contrôle des critères 3/6
Pharmocann Global has a total shareholder equity of ₪223.0K and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪2.2M and ₪2.0M respectively.
Informations clés
0%
Ratio d'endettement
₪0
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | ₪612.00k |
| Fonds propres | ₪223.00k |
| Total du passif | ₪1.95m |
| Total des actifs | ₪2.18m |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Analyse de la situation financière
Passif à court terme: PMCN-M's short term assets (₪1.1M) do not cover its short term liabilities (₪1.8M).
Passif à long terme: PMCN-M's short term assets (₪1.1M) exceed its long term liabilities (₪151.0K).
Historique et analyse du ratio d'endettement
Niveau d'endettement: PMCN-M is debt free.
Réduire la dette: PMCN-M has no debt compared to 5 years ago when its debt to equity ratio was 0.7%.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: PMCN-M has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.9% each year